Yumanity Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Yumanity Therapeutics has a total shareholder equity of $5.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $9.6M and $4.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$8.42m |
Equity | US$5.48m |
Total liabilities | US$4.10m |
Total assets | US$9.58m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: YMTX's short term assets ($9.1M) exceed its short term liabilities ($4.1M).
Long Term Liabilities: YMTX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: YMTX is debt free.
Reducing Debt: YMTX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: YMTX has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: YMTX is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.